Baldwin Wealth Partners LLC MA Reduces Stock Holdings in Zoetis Inc. $ZTS

Baldwin Wealth Partners LLC MA lessened its position in shares of Zoetis Inc. (NYSE:ZTS) by 0.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 77,422 shares of the company’s stock after selling 685 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in Zoetis were worth $12,074,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ZTS. Brighton Jones LLC grew its stake in Zoetis by 180.4% during the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after purchasing an additional 2,978 shares during the last quarter. Farther Finance Advisors LLC grew its stake in Zoetis by 11.1% during the 1st quarter. Farther Finance Advisors LLC now owns 4,738 shares of the company’s stock valued at $767,000 after purchasing an additional 474 shares during the last quarter. Simplicity Wealth LLC grew its stake in Zoetis by 16.2% during the 1st quarter. Simplicity Wealth LLC now owns 1,709 shares of the company’s stock valued at $281,000 after purchasing an additional 238 shares during the last quarter. SG Americas Securities LLC grew its stake in Zoetis by 61.8% during the 1st quarter. SG Americas Securities LLC now owns 20,782 shares of the company’s stock valued at $3,422,000 after purchasing an additional 7,940 shares during the last quarter. Finally, Simon Quick Advisors LLC grew its stake in Zoetis by 60.3% during the 1st quarter. Simon Quick Advisors LLC now owns 4,835 shares of the company’s stock valued at $796,000 after purchasing an additional 1,818 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Argus reiterated a “buy” rating and set a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Piper Sandler boosted their price objective on Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a report on Monday, August 11th. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a report on Wednesday. Finally, Stifel Nicolaus cut Zoetis from a “buy” rating to a “hold” rating and decreased their price objective for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $200.88.

Zoetis Stock Performance

NYSE ZTS opened at $143.32 on Friday. The stock has a market capitalization of $63.52 billion, a price-to-earnings ratio of 24.67, a PEG ratio of 2.30 and a beta of 0.90. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $196.55. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The stock has a 50-day moving average of $149.36 and a 200 day moving average of $154.60.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. The company had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis’s dividend payout ratio is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.